FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

ICE says 2 demonstrators were arrested in Minnesota for allegedly assaulting officers

Anti-ICE mob storms Minnesota church over pastor’s alleged ties to immigration enforcement

Nancy Pelosi faces social media backlash over behavior at Bob Weir tribute event

Newsom defies Trump administration, declares free parks for MLK Day

Kurdish SDF forces agree to ceasefire with Syrian government after offensive

Texas couple labeled fake ‘Chip and Joanna Gaines’ admits $5M dream home renovation scam

Wife of former American detainee released after more than a year in Venezuelan prison

Why Trump zeroed in on Greenland and why it matters in 3 maps

California man kills wife, teen daughter in murder-suicide: authorities

St. Louis Calls Off Search for Band of Monkeys Allegedly Accompanied by a Goat After AI Images Flood Social Media

Nobel Foundation weighs in after Machado presents Peace Prize to Trump

Leftist with ‘Any Pronouns’ Arrested for Assassination Threats Against Conservatives on Campus

‘Driver’s Licenses for All’: Minnesota’s Dangerous Surrender of the Rule of Law

Blue State Raids ‘Emergency’ Funds to Pay Off Student Loans, Could Fuel ‘Unsustainable’ Borrowing

California Mom Convicted of Murder After Drinking and Going Online for Dates as Daughter Drowned

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”